CIOMS Working Group on Vaccine SafetyA new CIOMS Working Group (WG) has been established to address issues related to the information exchange between stakeholders on vaccine safety. The formation of the new WG is linked to the activities of the Global Vaccine Safety Blueprint of WHO and its implementation plan, the Global Vaccine Safety Initiative (GVSI). It is a global strategic plan that aims at assisting low- and middle-income countries (LMIC) in their work with vaccine safety surveillance.

The importance of close collaboration between stakeholders is well recognized in vaccine pharmacovigilance activities, and guidance has been developed, in industrialized countries, for jointly planning these activities.

The new CIOMS working group on vaccine safety is established in order to provide a forum for information exchange and active interaction between industry and other stakeholders for the GVS Initiative as well as a “think-tank” that will develop and propose new concepts to the GVS Initiative and other global harmonization efforts in the field.  The main objectives are:

  • To promote a more efficient and rapid collection and exchange of information between NRAs, multilateral agencies and vaccine manufacturers (this should ideally be achieved through mutual publications).
  • To develop and endorse harmonized tools and methods for vaccine safety monitoring activities between national regulatory agencies, multilateral agencies and manufacturers.
  • To propose mechanisms for vaccine safety monitoring in difficult settings i.e. those with minimal infrastructure.

The initial duration of the Working Group is for three years but in order to align with that of the WHO GVS Initiative, this period may be considered for extension to 2020.

New Meetings

1st Working Group on DILI Meeting, Geneva, Switzerland, 27-28 April 2017

11th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 22-23 March 2017

CIOMS 84th Executive Committee Meeting, Geneva, Switzerland, 28 November 2017


Recent Meetings

83rd CIOMS Executive Committee/General Assembly Meeting, Geneva, Switzerland, 29 November 2016

10th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 6-7 September 2016

10th Working Group Meeting on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 1-3 June 2016

8th CIOMS Working Group Meeting on Vaccine Safety, Accra, Ghana, 22-23 March 2016

9th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 15-16 March 2016

82nd CIOMS Executive Committee Meeting, Geneva, Switzerland, 8 December 2015

ISoP meeting, Prague, Czech Republic, 27-30 October 2015

8th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 24-25 September 2015

7th CIOMS Working Group meeting on Vaccine Safety, near Philadelphia, PA, USA, 21-22 September 2015

8th Working Group X on Meta-analysis, New Brunswick, NJ, USA, 1-2 July 2015

9th Working Group on Revision of CIOMS International Ethical Guidelines, Paris, France, 14-16 June 2015

th Working Group on MedDRA IWG, Chavannes-de-Bogis, Switzerland, 19-20 May 2015

8th Working Group on Revision of CIOMS International Ethical Guidelines, Vilnius, Lithuania, 22-24 March 2015

6th Vaccine Safety Working Group, Lyon, France, 18-19 March 2015 

ISoP Meeting, Mysore, India, 12-14 January 2015


WHO on Twitter

WHO Q: Is it ethically correct to offer a test for drug resistant TB when the treatment is not available? A: Yes…
WHO RT @UNICEF: Tuberculosis is not a disease of the past! #WorldTBDay #endTB @WHO
WHO Q: Do governments have an ethical obligation to provide tuberculosis care for free? A: Yes
WHO More than a third (4.3 million) of people with #TB go undiagnosed or unreported, some receive no care at all…
WHO RT @WHOJordan: يمثل اليوم العالمي للسل فرصة لإذكاء الوعي بعبء السل في جميع أنحاء العالم والجهود المبذولة في مجال الوقاية منه ورعاية المصابي…



Member Login

Member Login